Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1
[Display omitted]
Gespeichert in:
| Veröffentlicht in: | Kidney international 2023-05, Vol.103 (5), p.990-993 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 993 |
|---|---|
| container_issue | 5 |
| container_start_page | 990 |
| container_title | Kidney international |
| container_volume | 103 |
| creator | Garrelfs, Sander F. Metry, Elisabeth L. van Harskamp, Dewi Vaz, Frederic M. van den Akker, Chris H.P. Schierbeek, Henk Groothoff, Jaap W. Oosterveld, Michiel J.S. |
| description | [Display omitted] |
| doi_str_mv | 10.1016/j.kint.2023.01.029 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783789458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253823001473</els_id><sourcerecordid>2783789458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-3e36f066dfa4b32a1612a8c5c22a53a37e040476d7f87b38e736906dd1c32a3b3</originalsourceid><addsrcrecordid>eNp9kEFr2zAYhkVZabO2f2CHoeMudj9JtiTDLiOsWaGwy3oWsvyZKHPsTJKb5N9PIemOO3288LwvfA8hnxiUDJh83JS__ZhKDlyUwErgzRVZsJqLgqm6_kAWALoueC30LfkY4wZybgTckFshtWJNpRfErYajmwabkE4H39mI1I9r3_rkp5G2RzrMWxt9sCN9s8FjpC2mPeJIdzZ5HFOke5_WdBf81oYjXR93GKaDHebgLU05UXZPrns7RHy43Dvy-vT91_JH8fJz9bz89lK4CiAVAoXsQcqut1UruGWScatd7Ti3tbBCIVRQKdmpXqtWaFRCNiC7jrlMi1bckS_n3V2Y_swYk9n66HAY7IjTHA1XWijdVLXOKD-jLkwxBuzN5QHDwJzkmo05yTUnuQaYyXJz6fNlf2632P2rvNvMwNczgPnLN4_BRJcdOex8QJdMN_n_7f8FhrCMmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2783789458</pqid></control><display><type>article</type><title>Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Garrelfs, Sander F. ; Metry, Elisabeth L. ; van Harskamp, Dewi ; Vaz, Frederic M. ; van den Akker, Chris H.P. ; Schierbeek, Henk ; Groothoff, Jaap W. ; Oosterveld, Michiel J.S.</creator><creatorcontrib>Garrelfs, Sander F. ; Metry, Elisabeth L. ; van Harskamp, Dewi ; Vaz, Frederic M. ; van den Akker, Chris H.P. ; Schierbeek, Henk ; Groothoff, Jaap W. ; Oosterveld, Michiel J.S.</creatorcontrib><description>[Display omitted]</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2023.01.029</identifier><identifier>PMID: 36871948</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alcohol Oxidoreductases ; Humans ; Hyperoxaluria ; Hyperoxaluria, Primary - diagnosis ; Hyperoxaluria, Primary - drug therapy ; Hyperoxaluria, Primary - genetics ; lumasiran ; Oxalates ; pediatric nephrology ; stable isotopes</subject><ispartof>Kidney international, 2023-05, Vol.103 (5), p.990-993</ispartof><rights>2023 International Society of Nephrology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-3e36f066dfa4b32a1612a8c5c22a53a37e040476d7f87b38e736906dd1c32a3b3</citedby><cites>FETCH-LOGICAL-c400t-3e36f066dfa4b32a1612a8c5c22a53a37e040476d7f87b38e736906dd1c32a3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36871948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garrelfs, Sander F.</creatorcontrib><creatorcontrib>Metry, Elisabeth L.</creatorcontrib><creatorcontrib>van Harskamp, Dewi</creatorcontrib><creatorcontrib>Vaz, Frederic M.</creatorcontrib><creatorcontrib>van den Akker, Chris H.P.</creatorcontrib><creatorcontrib>Schierbeek, Henk</creatorcontrib><creatorcontrib>Groothoff, Jaap W.</creatorcontrib><creatorcontrib>Oosterveld, Michiel J.S.</creatorcontrib><title>Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>[Display omitted]</description><subject>Alcohol Oxidoreductases</subject><subject>Humans</subject><subject>Hyperoxaluria</subject><subject>Hyperoxaluria, Primary - diagnosis</subject><subject>Hyperoxaluria, Primary - drug therapy</subject><subject>Hyperoxaluria, Primary - genetics</subject><subject>lumasiran</subject><subject>Oxalates</subject><subject>pediatric nephrology</subject><subject>stable isotopes</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFr2zAYhkVZabO2f2CHoeMudj9JtiTDLiOsWaGwy3oWsvyZKHPsTJKb5N9PIemOO3288LwvfA8hnxiUDJh83JS__ZhKDlyUwErgzRVZsJqLgqm6_kAWALoueC30LfkY4wZybgTckFshtWJNpRfErYajmwabkE4H39mI1I9r3_rkp5G2RzrMWxt9sCN9s8FjpC2mPeJIdzZ5HFOke5_WdBf81oYjXR93GKaDHebgLU05UXZPrns7RHy43Dvy-vT91_JH8fJz9bz89lK4CiAVAoXsQcqut1UruGWScatd7Ti3tbBCIVRQKdmpXqtWaFRCNiC7jrlMi1bckS_n3V2Y_swYk9n66HAY7IjTHA1XWijdVLXOKD-jLkwxBuzN5QHDwJzkmo05yTUnuQaYyXJz6fNlf2632P2rvNvMwNczgPnLN4_BRJcdOex8QJdMN_n_7f8FhrCMmA</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Garrelfs, Sander F.</creator><creator>Metry, Elisabeth L.</creator><creator>van Harskamp, Dewi</creator><creator>Vaz, Frederic M.</creator><creator>van den Akker, Chris H.P.</creator><creator>Schierbeek, Henk</creator><creator>Groothoff, Jaap W.</creator><creator>Oosterveld, Michiel J.S.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202305</creationdate><title>Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1</title><author>Garrelfs, Sander F. ; Metry, Elisabeth L. ; van Harskamp, Dewi ; Vaz, Frederic M. ; van den Akker, Chris H.P. ; Schierbeek, Henk ; Groothoff, Jaap W. ; Oosterveld, Michiel J.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-3e36f066dfa4b32a1612a8c5c22a53a37e040476d7f87b38e736906dd1c32a3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alcohol Oxidoreductases</topic><topic>Humans</topic><topic>Hyperoxaluria</topic><topic>Hyperoxaluria, Primary - diagnosis</topic><topic>Hyperoxaluria, Primary - drug therapy</topic><topic>Hyperoxaluria, Primary - genetics</topic><topic>lumasiran</topic><topic>Oxalates</topic><topic>pediatric nephrology</topic><topic>stable isotopes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garrelfs, Sander F.</creatorcontrib><creatorcontrib>Metry, Elisabeth L.</creatorcontrib><creatorcontrib>van Harskamp, Dewi</creatorcontrib><creatorcontrib>Vaz, Frederic M.</creatorcontrib><creatorcontrib>van den Akker, Chris H.P.</creatorcontrib><creatorcontrib>Schierbeek, Henk</creatorcontrib><creatorcontrib>Groothoff, Jaap W.</creatorcontrib><creatorcontrib>Oosterveld, Michiel J.S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garrelfs, Sander F.</au><au>Metry, Elisabeth L.</au><au>van Harskamp, Dewi</au><au>Vaz, Frederic M.</au><au>van den Akker, Chris H.P.</au><au>Schierbeek, Henk</au><au>Groothoff, Jaap W.</au><au>Oosterveld, Michiel J.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2023-05</date><risdate>2023</risdate><volume>103</volume><issue>5</issue><spage>990</spage><epage>993</epage><pages>990-993</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36871948</pmid><doi>10.1016/j.kint.2023.01.029</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2023-05, Vol.103 (5), p.990-993 |
| issn | 0085-2538 1523-1755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2783789458 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Alcohol Oxidoreductases Humans Hyperoxaluria Hyperoxaluria, Primary - diagnosis Hyperoxaluria, Primary - drug therapy Hyperoxaluria, Primary - genetics lumasiran Oxalates pediatric nephrology stable isotopes |
| title | Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T20%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycolate%20oxidase%20inhibition%20by%20lumasiran%20varies%20between%20patients%20with%20primary%20hyperoxaluria%20type%201&rft.jtitle=Kidney%20international&rft.au=Garrelfs,%20Sander%20F.&rft.date=2023-05&rft.volume=103&rft.issue=5&rft.spage=990&rft.epage=993&rft.pages=990-993&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2023.01.029&rft_dat=%3Cproquest_cross%3E2783789458%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2783789458&rft_id=info:pmid/36871948&rft_els_id=S0085253823001473&rfr_iscdi=true |